08 January 2013, Madison, WI USA: Promega Corporation announced today that it has launched Magne™ Protein A Beads for the purification of monoclonal and polyclonal antibodies from a range of diverse sources. These paramagnetic affinity beads offer a convenient method for achieving high purity and high recovery of immunoglobulins (Igs) from cell culture, ascites and serum samples. They may also be used for high-throughput antibody purification; antibody purification and concentration from small-volume or dilute source material; and for immunoglobulin depletion.
Magne Protein A Beads are composed of iron encapsulated by macroporous cellulose, resulting in low non-specific binding and high quality purification, they use a novel attachment chemistry to immobilize recombinant Protein A protein molecules in the same orientation on the surface of the bead. The oriented attachment is known to improve the functionality of immobilized proteins.Their highly magnetic properties allow ease of handling, and rapid and efficient capture using a variety of magnetic stands.
This new product compliments the Magne Protein G Beads recently launched.
For more information about Promega’s range of magnetic systems for purification of antibodies and affinity-tagged proteins please visit: www.promega.com/magne
Enquiries:
Katie Odgaard
Zyme Communications Ltd
Tel: +44 (0) 7787 502 947
Skype: kodgaard
Email: katie.odgaard@zymecommunications.com
www.zymecommunications.com
Penny Patterson
Sr. Director Communications
Promega Corporation
Phone: +1 (608) 274-4330
E-mail: penny.patterson@promega.com
www.promega.com
About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA, with branches in 15 countries and over 50 global distributors. For more information about Promega, visit: www.promega.com
